Deregulated cytokine network and defective Th1 immune response in multiple myeloma

Por Frassanito, M A, Cusmai, A, Dammacco, F
Publicado em 2001

Combined cyclosporin-A /prednisone therapy of patients with active uveitis suppresses IFN-γ production and the function of dendritic cells

Por FRASSANITO, M A, DAMMACCO, R, FUSARO, T, CUSMAI, A, GUERRIERO, S, SBORGIA, C
Publicado em 2003

Fas/Fas ligand (FasL)-deregulated apoptosis and IL-6 insensitivity in highly malignant myeloma cells

Por Frassanito, M A, Silvestris, F, Silvestris, N, Cafforio, P, Camarda, G, Iodice, G, Dammacco, F
Publicado em 1998

Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma

Por Desantis, V., Saltarella, I., Lamanuzzi, A., Mariggiò, M.A., Racanelli, V., Vacca, Angelo, Frassanito, M.A.
Publicado no Transl Oncol (2018)

JAM-A as a prognostic factor and new therapeutic target in multiple myeloma

Por Solimando, A G, Brandl, A, Mattenheimer, K, Graf, C, Ritz, M, Ruckdeschel, A, Stühmer, T, Mokhtari, Z, Rudelius, M, Dotterweich, J, Bittrich, M, Desantis, V, Ebert, R, Trerotoli, P, Frassanito, M A, Rosenwald, A, Vacca, A, Einsele, H, Jakob, F, Beilhack, A
Publicado no Leukemia (2018)